Neurim Pharmaceuticals is a neuroscience drug discovery and development company creating drugs for brain restoration & reinforcement, focusing on the central nervous system (CNS) with the goal of improving quality of life. Neurim Pharmaceuticals has developed innovative products and holds a promising pipeline of new chemical entities effective in CNS disorders. It was founded in 1991 and is a privately owned company and part of the RAD group (RAD.com) with its headquarters in Tel Aviv.